@article{013ab8222fd74f4198377a7bb634e3ba,
title = "Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases",
abstract = "Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.",
keywords = "C-peptide, diabetes mellitus, immune checkpoint inhibitor, insulin secretion",
author = "Noriko Fujiwara and Mayu Watanabe and Akihiro Katayama and Yohei Noda and Jun Eguchi and Hitomi Kataoka and Shunsuke Kagawa and Jun Wada",
note = "Funding Information: Jun Wada receives speaker honoraria from Astra Zeneca, Daiichi Sankyo, MSD, Novartis, Tanabe Mitsubishi, Taisho Toyama and receives grant support from Baxter, Chugai, Dainippon Sumitomo, Ono, Teijin. Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",
year = "2021",
month = sep,
doi = "10.1002/ccr3.4574",
language = "English",
volume = "9",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
number = "9",
}
